InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (27 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
27
T+90 hit rate
100%
T+90 mean return
+20.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Atlas Venture Fund X, L.P.. Director active across 4 companies, notably Kymera Therapeutics, Inc.. In total, 35 filings have been published. Split: 0 buy · 27 sells. Total volume traded: €64.2m. History available since 18 May 2021. The latest transaction was filed on 11 March 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations35 total
37,180 shares@ US$42.778.6% of flowCommon StockSEC:0001415889-24-007894:0
47,500 shares@ US$67.6520.0% of flowCommon StockSEC:0001209191-24-002231:0
30,000 shares@ US$64.0011.9% of flowCommon StockSEC:0001209191-24-001540:0
31,235 shares@ US$59.8711.8% of flowCommon StockSEC:0001209191-23-058707:0
94,440 shares@ US$53.0556.9% of flowCommon StockSEC:0001209191-23-049778:0
75,000 shares@ US$52.0024.3% of flowCommon StockSEC:0001209191-23-046110:0
21,683 shares@ US$29.963.6% of flowCommon StockSEC:0001209191-23-003293:0
882,224 sharesCommon StockSEC:0000899243-23-000461:1
1,835,799 sharesCommon StockSEC:0000899243-23-000461:0
112,819 shares@ US$30.2818.9% of flowCommon StockSEC:0001209191-22-061706:0
96,581 shares@ US$30.0217.3% of flowCommon StockSEC:0001209191-22-055808:0
94,239 shares@ US$30.2316.8% of flowCommon StockSEC:0001209191-22-055142:2
15,804 shares@ US$30.572.9% of flowCommon StockSEC:0001209191-22-055142:5
3,727 shares@ US$31.080.7% of flowCommon StockSEC:0001209191-22-055142:6
56,455 shares@ US$30.5710.3% of flowCommon StockSEC:0001209191-22-055142:4
26,383 shares@ US$30.234.7% of flowCommon StockSEC:0001209191-22-055142:3
19,915 shares@ US$30.003.5% of flowCommon StockSEC:0001209191-22-055142:1
71,135 shares@ US$30.0012.6% of flowCommon StockSEC:0001209191-22-055142:0
1,044 shares@ US$31.080.2% of flowCommon StockSEC:0001209191-22-055142:7
51,294 shares@ US$25.7015.5% of flowCommon StockSEC:0001209191-21-058122
51,294 shares@ US$25.7015.5% of flowCommon StockSEC:0001209191-21-058122:0
30,560 shares@ US$25.8919.3% of flowCommon StockSEC:0001209191-21-057719:0
30,560 shares@ US$25.8919.3% of flowCommon StockSEC:0001209191-21-057719
1,000,000 shares0Common StockSEC:0001209191-21-057041:0
1,000,000 shares0Common StockSEC:0001209191-21-057041
25 of 35 declarations
About Atlas Venture Fund X, L.P.
Atlas Venture Fund X, L.P. is a director and insider at Kymera Therapeutics, Inc. and Generation Bio Co.
